IRIS UniCatt

Siciliano, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.875
EU - Europa 2.441
AS - Asia 2.156
SA - Sud America 364
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 7.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.816
SG - Singapore 1.104
DE - Germania 1.003
CN - Cina 493
SE - Svezia 416
BR - Brasile 312
UA - Ucraina 208
IT - Italia 191
FR - Francia 173
VN - Vietnam 166
GB - Regno Unito 114
IE - Irlanda 103
FI - Finlandia 80
IN - India 65
ID - Indonesia 64
TR - Turchia 50
RU - Federazione Russa 42
JP - Giappone 40
HK - Hong Kong 37
CA - Canada 31
IQ - Iraq 24
BE - Belgio 23
AR - Argentina 22
IR - Iran 21
BD - Bangladesh 20
PL - Polonia 20
MX - Messico 18
CI - Costa d'Avorio 13
NL - Olanda 13
AE - Emirati Arabi Uniti 9
AT - Austria 9
PK - Pakistan 9
SA - Arabia Saudita 9
EC - Ecuador 8
EU - Europa 8
LT - Lituania 8
ZA - Sudafrica 7
AZ - Azerbaigian 6
MA - Marocco 6
UZ - Uzbekistan 6
VE - Venezuela 6
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
KG - Kirghizistan 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
BH - Bahrain 2
CO - Colombia 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AD - Andorra 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.887
Salva come PNG Salva come JPEG
Città #
Singapore 669
Chandler 469
Ashburn 261
San Jose 213
Jacksonville 121
Beijing 108
San Mateo 104
Dublin 102
Dallas 85
New York 79
Ann Arbor 74
The Dalles 66
Nürnberg 62
Jakarta 59
Ho Chi Minh City 58
Wilmington 58
Cattolica 57
Nanjing 57
Los Angeles 52
Lauterbourg 50
Boston 49
Munich 47
Dearborn 46
Hanoi 46
Woodbridge 39
Izmir 38
Tokyo 38
Frankfurt am Main 35
Helsinki 32
Marseille 32
Princeton 32
Redwood City 31
Hong Kong 29
Nanchang 27
Bremen 26
Houston 26
Moscow 26
Zhengzhou 25
Brussels 23
Lawrence 23
São Paulo 23
Rome 21
Tianjin 21
Augusta 20
Hangzhou 20
Hefei 20
Santa Clara 20
Lancaster 19
Leawood 19
Andover 18
Hebei 17
Buffalo 16
Seattle 16
Warsaw 16
Shenyang 15
Boardman 14
Milan 14
Phoenix 14
Abidjan 13
Changsha 13
Fairfield 13
Orem 13
Shanghai 13
Falls Church 12
Paris 12
Turku 12
Kunming 11
London 11
Stockholm 11
Amsterdam 10
Atlanta 10
Norwalk 10
University Park 10
Guangzhou 9
Toronto 9
Baghdad 8
Chicago 8
Curitiba 8
Kish 8
Nuremberg 8
Rio de Janeiro 8
Salvador 8
Bologna 7
Da Nang 7
Jiaxing 7
Las Vegas 7
Mountain View 7
Brooklyn 6
Chennai 6
Detroit 6
Dhaka 6
Goiânia 6
Haiphong 6
Jinan 6
Kent 6
Mcallen 6
Montreal 6
Riyadh 6
Tashkent 6
Amman 5
Totale 4.157
Salva come PNG Salva come JPEG
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 246
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 242
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 203
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 199
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 191
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 183
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 177
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 175
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 173
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 169
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 165
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 165
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 159
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 159
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Microscopic colitis 157
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 157
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 156
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 146
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 140
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 139
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 139
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 137
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 136
Model for end-stage liver disease dynamic stratification of survival benefit 136
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 136
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 135
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 131
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 128
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 128
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 127
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 126
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 126
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 124
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 121
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 120
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 117
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 116
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 116
Regorafenib: a promising treatment for hepatocellular carcinoma 115
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 114
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 109
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 106
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 104
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 99
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 97
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 92
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 85
The new era of hepatitis C treatment: still the tip of the iceberg? 83
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 83
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 75
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 71
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 71
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 61
Totale 7.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.724
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 33 99 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025964 16 34 84 23 111 28 25 48 149 99 196 151
2025/20262.503 397 51 178 275 601 142 458 109 154 138 0 0
Totale 7.977